Evaluation of tissue-engineered vascular autografts

Tissue Engineering

Volumn 12, Issue 11, 2006, Pages 3075-3083

  Matsumura, Goki ^a   Ishihara, Yoko ^b   Miyagawa Tomita, Sachiko ^a   Ikada, Yoshito ^c   Matsuda, Shojiro ^d   Kurosawa, Hiromi ^a   Shin'oka, Toshiharu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d GUNZE Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFERIOR VENA CAVA (IVC) MODEL; MONONUCLEAR BONE MARROW CELLS (MN-BMC); POLYGLYCOLIDE FIBERS; TISSUE-ENGINEERED VASCULAR AUTOGRAFTS (TEVA);

BIODEGRADATION; BIOMECHANICS; CELLS; SCAFFOLDS; TISSUE; TRANSPLANTATION (SURGICAL);

BIOMEDICAL ENGINEERING;

ACETYLCHOLINE; BLOOD CLOTTING FACTOR 8; COPOLYMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC ACID DERIVATIVE; NITRITE; POLY(LACTIDE CO EPSILON CAPROLACTONE); POLYGLYCOLIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; BLOOD VESSEL GRAFT; BONE MARROW CELL; CALCIFICATION; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; EXPLANT; FEMALE; HISTOLOGY; IMPLANTATION; INFERIOR CAVA VEIN; INFLAMMATORY CELL; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THICKNESS; TISSUE ENGINEERING; VENOUS PRESSURE;

ACETYLCHOLINE; ANIMALS; ANTICOAGULANTS; ANTIGENS, CD4; BIOCOMPATIBLE MATERIALS; BIOMECHANICS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FACTOR VIII; FEMALE; IMMUNOHISTOCHEMISTRY; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; POLYESTERS; POLYGLYCOLIC ACID; RNA, MESSENGER; TIME FACTORS; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS; VASODILATOR AGENTS; VENA CAVA, INFERIOR; VENOUS PRESSURE;

CANIS FAMILIARIS;

EID: 33751576149     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.3075     Document Type: Article

References (24)

1. Matsumura, G., Miyagawa-Tomita, S., Shin'oka, T., Ikada, Y., and Kurosawa, H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108, 1729, 2003.
2. Moncada, S., and Higgs, A. The L-arginine-nitric oxide pathway. N Engl J Med 329, 2002, 1993.
3. Radomski, M.W., Palmer, R.M., and Moncada, S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 87, 5193, 1990.
4. Moncada, S., Palmer, R.M., and Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109, 1991.
5. Ziche, M., Morbidelli, L., Masini, E., Granger, H., Geppetti, P., and Ledda, F. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 192, 1198, 1993.
6. Babaei, S., Teichert-Kuliszewska, K., Zhang, Q., Jones, N., Dumont, D.J., and Stewart, D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162, 1927, 2003.
7. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., and Sessa, W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100, 3131, 1997.
8. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin'oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
9. Tsukamoto, Y., Ishihara, Y., Miyagawa-Tomita, S., and Hagiwara, H. Inhibition of ossification in vivo and differentiation of osteoblasts in vitro by tributyltin. Biochem Pharmacol 68, 739, 2004.
10. Nakajima, Y., Morishima, M., Nakazawa, M., and Momma, K. Inhibition of outflow cushion mesenchyme formation in retinoic acid-induced complete transposition of the great arteries. Cardiovasc Res 31 Spec No, E77, 1996.
11. Murohara, T., Witzenbichler, B., Spyridopoulos, I., Asahara, T., Ding, B., Sullivan, A., Losordo, D.W., and Isner, J.M. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 19, 1156, 1999.
12. Kamihata, H., Matsubara, H., Nishiue, T., Fujiyama, S., Tsutsumi, Y., Ozono, R., Masaki, H., Mori, Y., Iba, O., Tateishi, E., Kosaki, A., Shintani, S., Murohara, T., Imaizumi, T., and Iwasaka, T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104, 1046, 2001.
13. Shi, Q., Rafii, S., Wu, M.H., Wijelath, E.S., Yu, C., Ishida, A., Fujita, Y., Kofhari, S., Mohle, R., Sauvage, L.R., Moore, M.A., Storb, R.F., and Hammond, W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362, 1998.
14. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964, 1997.
15. Chae, J.K., Kim, I., Lim, S.T., Chung, M.J., Kim, W.H., Kim, H.G., Ko, J.K., and Koh, G.Y. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20, 2573, 2000.
16. Kim, I., Moon, S.O., Koh, K.N., Kim, H., Uhm, C.S., Kwak, H.J., Kim, N.G., and Koh, G.Y. Molecular cloning, expression, and characterization of angiopoietin-related protein, angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 274, 26523, 1999.
17. Babaei, S., Teichert-Kuliszewska, K., Monge, J.C., Mohamed, F., Bendeck, M.P., and Stewart, D.J. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 82, 1007, 1998.
18. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Geppetti, P., and Ledda, F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94, 2036, 1994.
19. Babaei, S., and Stewart, D.J. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc Res 55, 190, 2002.
20. Morbidelli, L., Orlando, C., Maggi, C.A., Ledda, F., and Ziche, M. Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol 269, H686, 1995.
21. Ku, D.D., Zaleski, J.K., Liu, S., and Brock, T.A. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265, H586, 1993.
22. van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., and Isner, J.M. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95, 1030, 1997.
23. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J.F., Fishman, M.C., Huang, P.L., and Isner, J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101, 2567, 1998.
24. Isomatsu, Y., Shin'oka, T., Matsumura, G., Hibino, N., Konuma, T., Nagatsu, M., and Kurosawa, H. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg 126, 1958, 2003.